Januvia Tablet, Film Coated
Product Images NDC 50090-1036

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Januvia (NDC 50090-1036). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Sitagliptin Chemical Structure (Januvia 01)

Image Of Sitagliptin Chemical Structure (Januvia 01)
Chemical structure diagram showing the molecular structure of sitagliptin phosphate monohydrate, the active ingredient in JANUVIA 100 mg tablets. The diagram includes fluorine and trifluoromethyl groups and depicts the compound with phosphate and water molecules.*
FDA Label Image

Image Of Figure 1 (Januvia 02)

Image Of Figure 1 (Januvia 02)
A line graph showing the least squares mean change from baseline over 24 weeks for different treatments, including Placebo, Sitagliptin 100 mg once daily, Metformin 500 mg twice daily, Metformin 1000 mg twice daily, and combinations of Sitagliptin 50 mg twice daily with Metformin 500 mg or 1000 mg twice daily. The x-axis represents time in weeks and the y-axis represents the change in the measured outcome.*
FDA Label Image

Image Of Figure 2 (Januvia 03)

Image Of Figure 2 (Januvia 03)
A line graph showing the least squares mean change from baseline over 52 weeks for Januvia 100 mg and Glipizide. The x-axis represents the week number (0 to 52), and the y-axis shows the LS mean change, with both treatments showing a decreasing trend initially and then slightly increasing toward the end of the period.*
FDA Label Image

Label Image (Lbl500901036)

Label Image (Lbl500901036)
JANUVIA 100 mg film-coated oral tablets in a package labeled for 30 tablets, produced by A-S Medication Solutions. The label specifies sitagliptin as the active ingredient with each tablet containing 100 mg of sitagliptin phosphate, equivalent to 100 mg sitagliptin. Storage instructions note keeping at 20 to 25 degrees Celsius.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.